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Abstract
Sex differences in rates of depression are thought to contribute to sex differences in
smoking initiation (SI) and number of cigarettes smoked per day (CPD). One hypothesis is
that women smoke as a strategy to cope with anxiety and depression, and have difficulty
quitting because of concomitant changes in hypothalamic–pituitary–adrenocortical (HPA)
axis function during nicotine withdrawal states. Despite evidence of biological ties, research
has not examined whether genetic factors that contribute to depression-smoking comorbid-
ity differ by sex. We utilized two statistical aggregation techniques—polygenic scores (PGSs)
and sequence kernel association testing—to assess the degree of pleiotropy between these
behaviors and moderation by sex in the Health and Retirement Study (N = 8,086). At the
genome-wide level, we observed associations between PGSs for depressive symptoms and
SI, and measured SI and depressive symptoms (all p < .01). At the gene level, we found evi-
dence of pleiotropy in FKBP5 for SI (p = .028), and sex-specific pleiotropy in females in
NR3C2 (p = .030) and CHRNA5 (p = .025) for SI and CPD, respectively. Results suggest bidi-
rectional associations between depression and smoking may be partially accounted for by
shared genetic factors, and genetic variation in genes related to HPA-axis functioning and
nicotine dependence may contribute to sex differences in SI and CPD.
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1 | INTRODUCTION
Nearly 36.5 million (15.1%) U.S. adults are current cigarette smokers
(Jamal et al., 2016). Tobacco use is the leading cause of preventable
morbidity and mortality; the health effects of smoking include many
types of cancer, respiratory diseases, cardiovascular disease, and
adverse reproductive outcomes (Centers for Disease Control and Pre-
vention [CDC], 2014).
Though 20th century sex-related demographic trends in smoking
prevalence have persisted, with men smoking more than women do,
this gap is narrowing. Shrinking rates in smoking prevalence by sex
have been consistent (CDC, 2002; Cheng & Kenkel, 2010; Hammond,
2009; Jamal et al., 2016; Peters, Huxley, & Woodward, 2014). Con-
vergence in smoking rates by sex appear to be especially pronounced
in teens (CDC, 2002), with some reports showing that girls are
smoking more than boys (Substance Abuse Mental Health Services
Administration [SAMHSA], 2007). Research from population based
studies and placebo-controlled nicotine replacement trials have also
found women evince more quit attempts and have higher rates of
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relapse than men (Hammond, 2009; Perkins, 2001; Perkins & Scott,
2008; Pogun & Yararbas, 2009; Reynoso, Susabda, & Cepeda-Benito,
2005), suggesting that biological factors, in addition to social norms,
may contribute to sex differences in smoking behavior.
1.1 | Sex differences in biopsychosocial predictors of
smoking
Increasingly, sex differences in nicotine dependence have been linked
to biopsychosocial predictors of smoking, including sex differences in
depression (Perkins, 2001; Torres & O'Dell, 2016) and hypothalamic–
pituitary–adrenocortical (HPA) axis functioning. Clinically, major depres-
sive disorder (MDD) is more prevalent in women than in men (Hankin &
Abramson, 2001; McLaughlin, Xuan, Subramanian, & Koenen, 2011), and
women with a history of smoking are at higher risk of past and current
MDD than men (Husky, Mazure, Paliwal, & McKee, 2008). Women also
report greater perceived risks from quitting smoking, including greater
negative affect—a key feature of MDD (McKee, O'Malley, Salovey,
Krishnan-Sarin, & Mazure, 2005). Moreover, though concurrent depres-
sion and cigarette consumption are comorbid across sex (John, Meyer,
Rumpf, & Hapke, 2004), longitudinal data suggests that only among
women are there bidirectional associations between smoking behavior
and depression over time (Bares, 2014).
One of the most well studied biological processes linked to depression
is functioning of theHPA-axis, with documented sex differences in how this
process unfolds. The HPA-axis forms one component of the physiological
stress response by coordinating the release of glucocorticoids (i.e., cortisol
in humans) from the adrenal gland (Gunnar&Quevedo, 2007). As the princi-
ple tobacco alkaloid (Benowitz, Hukkanen, & Jacob, 2009), nicotine stimu-
lates greater secretion of HPA-axis hormones (e.g., cortisol), processes that
are mediated by nicotine binding to nicotinic acetylcholinergic receptors
expressed widely in the central nervous system (Rohleder & Kirschbaum,
2006; Tweed,Hsia, Lutfy, & Friedman, 2012). Though themolecularmecha-
nisms of nicotine initiation and HPA-axis functioning may be similar across
males and females, females show relatively greater circulating stress-related
HPA-axis hormones during nicotine withdrawal (Hogle & Curtin, 2006).
Moreover, negative mood states such as anxiety and depression that
accompany such HPA-axis changes are also more prevalent during nicotine
withdrawal for females than males (Hogle & Curtin, 2006; Soyster, Anzai,
Fromont, & Prochaska, 2016). Together, this research suggests that com-
pared to males, females are more susceptible to smoking as a strategy
to cope with increased anxiety and depression, and have more diffi-
culty quitting because of concomitant changes in HPA-axis function
during withdrawal states (Torres & O'Dell, 2016), both of which may
contribute to sex differences in smoking behavior and cessation.
1.2 | Do pleiotropic effects underlie sex-differences
in smoking behavior?
Results from LD score regression analyses of genome-wide association
study (GWAS) studies have shown evidence of genetic correlation
between smoking initiation (SI), smoking intensity or cigarettes smoked
per day (CPD), and depressive symptoms, or evidence that the effects
of genetic variants for these traits are correlated (Bulik-Sullivan et al.,
2015; Zheng et al., 2017). Table 1 reports cross-trait LD score regres-
sion estimates of genetic correlation from LD Hub that were calculated
using the most recent GWAS summary statistics of depressive symp-
toms, SI, and CPD (Zheng et al., 2017). Depressive symptoms are posi-
tively correlated with both SI and CPD, but are statistically more
significant for SI (rg = 0.249; p = 9.96E−06) than CPD (rg = 0.253;
p = .005). In females, results from twin studies indicate a stronger
genetic basis for smoking behavior (Li, Cheng, Ma, & Swan, 2003), and
the presence of an underlying genetic basis for a common predisposition
to smoking and depression (Dierker, Avenevoli, Stolar, & Merikangas,
2002; Kendler et al., 1993).
The genetic correlation between depression and smoking behavior
observed from twin studies or LD score regression could arise through
multiple mechanisms, but the most common interpretation is that they
arise as a result of pleiotropy—i.e., that alleles affecting one trait on
average also affect a second trait. However, despite the strong biolog-
ical links in the literature between smoking, depression, and HPA-axis
function in females, few studies have examined the existence of sex-
specific pleiotropic effects between genetic variants for depression
and smoking. Pleiotropic effects between depression and smoking
could manifest as biological or mediated pleiotropy (Figure 1). Biologi-
cal pleiotropy occurs when a genetic variant or gene has a direct bio-
logical influence on more than one phenotypic trait, whereas
mediated pleiotropy occurs when one phenotype is itself causally
related to a second phenotype so that a variant or gene associated
with the first phenotype is indirectly associated with the second
(Solovieff, Cotsapas, Lee, Purcell, & Smoller, 2013). Both are consid-
ered real forms of pleiotropy; however, it is important to distinguish
between the two in order to accurately identify the etiological mecha-
nisms of the two phenotypes (Solovieff et al., 2013).
Genetic variation underlying HPA-axis functioning is a plausible can-
didate neurobiological system in which to examine pleiotropic effects
between smoking and depression (Rovaris, Mota, & Bau, 2016; Torres &
O'Dell, 2016). Hyperactivation of the HPA-axis response, associated with
depression and nicotine withdrawal, is thought to reflect inefficient feed-
back inhibition by endogenous cortisol (Pariante & Lightman, 2008).
Many genes contribute to the initiation and regulation of the HPA-axis
(Arnett, Muglia, Laryea, & Muglia, 2016), including NR3C1, NR3C2,
FKBP5, and CRHR1 (Figure 2). Though several studies have linked SNP-
level variation within these genes to depression (see reviews by Arnett
TABLE 1 LD score regression estimates of genetic correlation for
depressive symptoms and smoking behaviors
Phenotype 1 Phenotype 2 rg (SE) p-value
Depressive symptoms CPD 0.253 (0.09) .005
Depressive symptoms SI 0.249 (0.056) 9.96E−06
Depressive symptoms Former smoker −0.158 (0.096) .101
Note: LD score regression estimates were downloaded from LD Hub
(Zheng et al., 2017), retrieved from http://ldsc.broadinstitute.org/lookup/.
Abbreviations: CPD, cigarettes per day; LD, linkage disequilibrium; rg,
genetic correlation; SE, standard error; SI, smoking initiation.
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et al., 2016; Gillespie, Phifer, Bradley, & Ressler, 2009), only a handful of
studies have examined associations with smoking behavior. For example,
Rogausch, Kochen, Meineke, and Hennig (2007) found that G allele
carriers at rs41423247 of NR3C1 were more likely to become smokers
and had significantly higher daily cigarette consumption than C homozy-
gotes. Other SNPs within NR3C2, FKBP5, and CRHR1 have also been
examined in relation to smoking outcomes (dos Santos et al., 2012;
Jensen et al., 2015; Koopmann et al., 2016; Rovaris et al., 2013; Tang
et al., 2015), with mixed results. Interestingly, a small GWAS of daily ciga-
rette use reported associations at SNPs within NR3C2, providing
additional evidence that genes underlying HPA-axis function may also
play a role in smoking behavior. Moreover, research suggests that
sex differences in corticotropin-releasing hormone signaling may
underlie greater female vulnerability for stress-related psychiatric
disorders (Bangasser et al., 2010). Thus, in the literature it is not
clear whether genetic variants in HPA-related genes influence
smoking via increased stress-related cortisol levels in individuals
(particularly females ) with depressive symptoms, or whether there
is an additional effect of these variants on smoking independent of
their effects on depression.
1.3 | Statistical approaches to testing pleiotropy with
molecular genetic data
More recently, studies have begun using GWAS findings to identify
pleiotropic effects at the genome-wide or gene-region level. At the
genome-wide level, genetic overlap can be assessed by testing
whether a polygenic score (PGS) for the first phenotype is significantly
associated with the second phenotype. A PGS applies weights from a
GWAS to genotype data to construct a weighted sum of genetic risk
for a phenotype. Using a PGS increases power to detect cross-
phenotype associations because it combines the cumulative effect sizes
of all genetic variants across the genome for an outcome into a single
scalar of genetic propensity (Dudbridge, 2013). Thus, PGSs can be eas-
ily incorporated into a multiple regression framework to simultaneously
test for biological or mediated pleiotropy and/or moderation by sex.
Past studies have used this approach to examine common genetic
effects that underlie schizophrenia and bipolar disorder (Purcell et al.,
2009), type 2 diabetes and hypertension (Lee, Yang, Goddard, Vis-
scher, & Wray, 2012), and MDD and risk of alcohol dependence
(Andersen et al., 2017). A downside to this approach is it does not
F IGURE 1 Biological and mediated pleiotropy. (a) Biological
pleiotropy: A variant or gene region affects depressive symptoms and
smoking behavior. (b) Mediated pleiotropy: A variant or gene region
affects depressive symptoms, which in turn affect smoking behavior.
As a result, an association is observed between the variant or gene
region and both phenotypes
F IGURE 2 Propagation of the hypothalamic–
pituitary–adrenocortical (HPA) axis. The CRH
receptor type 1 is encoded by CRHR1. NR3C1 and
NR3C2 encode GRs and MRs, respectively. FKBP5
is encoded by FKBP5. ACTH, adrenocorticotropic
hormone; CRH, corticotropin-releasing-hormone;
FKBP5, FK506-binding protein 51; GCs,
glucorticoids (i.e., cortisol in humans); GR,
glucocorticoid receptors; MRs, mineralocorticoid
receptors
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implicate a particular region of the genome and any related biological
processes that may be driving cross-phenotype associations.
One alternative to the polygenic approach is the use of sequence
kernel association testing (SKAT) or other region-based tests, which
use gene aggregation techniques to test for associations between
gene regions and a phenotype. SKAT improves upon the limited
power of single-marker association studies by testing for associations
between common and rare variants within a gene region, which
increases the power to detect true effects while also maintaining bio-
logical specificity (Wu et al., 2011). This approach requires a priori
knowledge of potential biologically relevant gene regions, which may
be challenging to determine in the context of cross-phenotype associa-
tions of complex polygenic traits. As a result, the use of both aggrega-
tion methods may be desirable; polygenic approaches are well powered
to identify the existence of pleiotropy between two phenotypes on a
global level, while regional methods can provide a more detailed map-
ping of specific genes that may be driving these associations.
1.4 | Current study
The current study utilized both polygenic and gene region aggregation
techniques to assess (a) the presence of biological or mediated pleiot-
ropy between genetic risk factors for depression or genes implicated
in HPA-axis functioning and smoking behavior, and (b) whether pleio-
tropic effects vary by sex. To accomplish these aims, we used data on
8,086 participants from the Health and Retirement Study (HRS)—a
large, population-representative study with detailed genetic and
sociodemographic data. To assess pleiotropy at the genome-wide
level, we first constructed a PGS using results from a recent GWAS of
depressive symptoms (Okbay et al., 2016) and tested associations
between the PGS and smoking behavior as well as moderation by sex.
Gene ontology analysis from the GWAS of depressive symptoms
implicated SNPs in genomic regions related to enrichment of the cen-
tral nervous system and the adrenal/pancreas (Okbay et al., 2016,
p. 628), both of which may capture stress-related HPA-axis function
in smokers. We used SKAT and interaction-SKAT (iSKAT) to examine
independent and sex-specific associations between smoking behavior
and gene regions that have been directly linked to HPA-axis function-
ing in both animal and human models, including NR3C1, NR3C2,
FKBP5, and CRHR1 (Figure 2).
Importantly, literature on the prospective associations between
smoking, depression, and anxiety in longitudinal studies has been incon-
sistent in terms of the direction of association (for a review, see
Fluharty, Taylor, Grabski, & Munafò, 2016). Since the HRS is a repre-
sentative sample of older adults, we could not assess whether the onset
of depression preceded tobacco use earlier in the life course. Therefore,
we also tested for pleiotropy in the reciprocal direction, or for signifi-
cant associations between genetic risk for smoking and a phenotype
for depressive symptoms. For these analyses we used PGSs con-
structed from a GWAS of SI and CPD (Furberg et al., 2010), and SKAT
and iSKAT analyses of the BDNF and CHRNA5 gene regions, which
have been implicated in previous studies of SI and nicotine dependence
(Furberg et al., 2010; Liu et al., 2010; Thorgeirsson et al., 2010).
2 | METHODS
2.1 | Study sample
The HRS is a nationally representative, longitudinal panel study of indi-
viduals over the age of 50 and their spouses (Juster & Suzman, 1995;
Sonnega et al., 2014) that is sponsored by the National Institute on Aging
(NIA U01AG009740) and conducted by the University of Michigan.
Launched in 1992, the HRS introduces a new cohort of participants
every 6 years and interviews around 20,000 participants every 2 years.
Genotype data on ~15,000 HRS participants was collected from a
random subset of the ~26,000 total participants that were selected to
participate in enhanced face-to-face interviews and saliva specimen col-
lection for DNA in 2006, 2008, and 2010. Since the HRS respondents
are from various ancestral backgrounds, and we used results from GWAS
of European ancestry (EA) to construct our PGS, we report results from
the HRS EA sample in the main text, because the PGS will not have the
same predictive power in non-European populations (Carlson et al., 2013;
Martin et al., 2017; see Section 2.2 for details on population assignment).
Restricting our analyses to one ancestral group is also important in that
SNPs within regions of interest may tag different causal variants if the
underlying linkage disequilibrium (LD) structure varies across ancestral
groups (Martin et al., 2017; Rosenberg et al., 2010). However, for com-
pleteness, we report corresponding methods and results from explor-
atory, cross-ancestry analyses in the HRS African ancestry (AA) sample in
Data S1 Supporting Information for this study (n = 1,984). We also
excluded participants born before 1930 due to documented mortality
selection, or increased survival among low risk smoking genotypes, in ear-
lier birth cohorts (Domingue et al., 2017), and spouses born after 1959,
since these individuals are not part of the core population-representative
HRS sample. Our final EA sample includes 8,086 respondents born
between 1930 and 1959.
2.2 | Genotyping and quality control
Genotyping was conducted by the Center for Inherited Disease Research
(CIDR) in 2011, 2012, and 2015 (RC2 AG0336495, RC4 AG039029). Full
quality control details can be found in the Quality Control Report (Quality
Control Report for Genotypic Data, 2013). Genotype data on over 15,000
HRS participants was obtained using the llumina HumanOmni2.5
BeadChips (HumanOmni2.5-4v1, HumanOmni2.5-8v1), which measures
~2.4 million SNPs. Genotyping quality control was performed by the
Genetics Coordinating Center at the University of Washington, Seattle,
WA. Individuals with missing call rates >2%, SNPs with call rates <98%,
HWE p-value <.0001, chromosomal anomalies, and first-degree relatives in
the HRS were removed. Imputation to 1000G Phase I v3 (released March
2012) was performed using SHAPEIT2 followed by IMPUTE2. The world-
wide reference panel of all 1,092 samples from the phase I integrated variant
set was used. These imputation analyses were performed and documented
by the Genetics Coordinating Center at the University of Washington, Seat-
tle, WA. All positions and names are aligned to build GRCh37/hg19.
Principal component (PC) analysis was performed on a selected
set of independent SNPs to identify population group outliers and to
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provide sample eigenvectors as covariates in the statistical model to
adjust for possible population stratification, and were provided by
the HRS. The EA sample included all respondents that had PC load-
ings within ±1 standard deviations (SDs) for eigenvectors one and
two in the PC analysis of all unrelated study subjects and who self-
identified as White on survey data. A second set of PCs was then
generated for the analytical EA sample to further account for any
population stratification within the EA sample. The EA genotype




2.3.1 | Smoking phenotypes
We examined two elements of smoking behavior: SI and smoking inten-
sity. For SI, we used the classification of “ever smoker” from the CDC,
which defines a smoker as someone who reports smoking 100 cigarettes
or more in their lifetime (CDC, 2008). We assigned a value of “1” for SI if
a respondent reports ever being a smoker at baseline when they entered
the HRS or in subsequent waves of the HRS. For smoking intensity, we
used number of CPD. If a respondent currently smokes, the HRS asks
how many cigarettes they currently smoke per day on average. If the
respondent no longer smokes, they are asked how many cigarettes they
smoked per day when they were smoking the most. Past studies in other
longitudinal cohorts have found a high overall correlation between these
variables over time, supporting the idea of using either value as a general
assessment of CPD (Furberg et al., 2010).
2.3.2 | Depressive symptoms phenotype
We pooled all available waves of HRS data and used the mean score
respondents received on the Center for Epidemiological Studies-
Depression (CES-D) scale eight item short form (Radloff, 1977; Watson,
1988; Watson, Wiese, Vaidya, & Tellegen, 1999). Participants indicated if
they experienced each item much of the time during the past week using
(1 = yes, 0 = no). We summed negative indicators (depressed, activities
were an effort, sleep is restless, felt lonely, felt sad, and unmotivated) and
reverse-coded positive indicators (felt happy and enjoyed life) to con-
struct an overall score (range [0, 8]). Mean CES-D scores included up to
11 waves of data.
2.3.3 | Covariates
We included the first 10 PCs of the genetic data (see Section 2.2), edu-
cational attainment (1 = GED/HS degree or higher; 0 = no degree), age
(respondent mean across all waves), and birth cohort (indicator vari-
ables for 6-year time spans, or 1930–1935, 1936–1941, 1942–1947,
1948–1953, and 1954–1959). In models with CPD as the outcome, we
also controlled for current versus former smoker status. The association
between educational attainment and smoking behavior has been well-
documented (e.g., de Walque, 2010; Pampel, 2009; Pampel, Krueger, &
Denney, 2010), and evidence also suggests a strong association
between education and depressive symptoms (Adler et al., 1994; Lorant
et al., 2003). Smoking behavior and self-reported depressive symptoms
have also been shown to vary significantly by birth cohort (Jeuring
et al., 2018; Weinberger et al., 2018). As depressive symptoms tend to
increase with age, we controlled for the mean age of the respondent
across all HRS waves to ensure any differences we observed by
sex were not related to average age at reporting (Blazer, Burchett,
Service, & George, 1991).
2.4 | Polygenic scores
Linear PGSs for depressive symptoms were constructed using effect
sizes from the largest GWAS of depressive symptoms to date con-
ducted by the Social Science and Genetics Association Consortium
(SSGAC) on EA individuals. The SSGAC meta-analyzed publicly avail-
able results from a study performed by the Psychiatrics Genomics
Consortium (PGC; Ripke et al., 2013) with GWAS results from the ini-
tial release of UK Biobank genetic data (total N = 180,666; Okbay
et al., 2016). A replication analysis was performed using data from
23andMe (N = 368,890). Since the HRS was part of the original
GWAS meta-analysis discovery sample, weights were re-estimated by
the SSGAC to exclude the HRS. Due to privacy constraints, these
weights do not contain data from 23andMe.
Linear PGSs for SI and CPD were constructed using effect sizes from
a GWAS meta-analyses of EA individuals conducted by the Tobacco and
Genetics Consortium (TAG; Furberg et al., 2010). For SI and CPD, a total
of 74,053 participants were included in the discovery phase of the analy-
sis; in a follow up meta-analysis of the 15 most significant regions,
143,023 participants were included for SI and 73,853 for CPD.
Genotyped SNPs in the HRS genetic database were matched to
SNPs with reported results in the GWAS. In the HRS EA genetic data,
1,126,742 genotyped SNPs were available to construct the depressive
symptoms PGS, 710,288 SNPs were available to construct the SI PGS,
and 767,171 SNPs were available to construct the CPD PGS. To
increase the power of its predictive capacity, SNPs included in the
PGSs were not trimmed for LD and a p-value threshold or cut-off was
not imposed (Andersen et al., 2017; Stein et al., 2017; Ware, Schmitz,
Gard, & Faul, 2018). The PGSs were calculated as a weighted sum of
the number of disease-associated alleles (zero, one, or two) at each
SNP multiplied by the effect size for that SNP estimated from the
GWAS meta-analysis. All SNPs were coded to be associated with
increasing disease risk. To simplify interpretation, all PGSs were stan-
dardized to have a mean of zero and SD of one.
Importantly, to test if adjustments for LD affected our genome-
wide tests for pleiotropy, we also estimated results with a depressive
symptoms PGS constructed in the software LDpred (Vilhjálmsson
et al., 2015). LDpred uses a Bayesian method to calculate PGSs that
estimates posterior mean effect sizes from GWAS summary statistics
by assuming a prior for the genetic architecture and LD information
from a reference panel. We used the EA HRS sample as the reference
panel with an LD window of 180 and the fraction of SNPs with non-
zero effects assumed to be one.
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2.5 | Identification of HPA-axis and smoking gene
regions
We examined four genes that support the propagation of the HPA-
axis: NR3C1, NR3C2, FKBP5, and CRHR1 (see Data S1 Supporting
Information for gene information). Figure 2 depicts how the proteins
that each of these genes encode support the HPA-axis response, both
in terms of initiation and regulation (Gunnar & Quevedo, 2007;
Lupien, McEwen, Gunnar, & Heim, 2009). Though many genes sup-
port the HPA-axis response (Arnett et al., 2016), we chose genes that
have been robustly linked to function of the HPA-axis in animal and
human models and studied in humans with regards to stress-related
psychiatric disorders. Using gene knockout models in mice and human
studies of genetic variation, NR3C1, NR3C2, FKBP5, and CRHR1 have
each been linked to the production of glucorticoids (i.e., cortisol in
humans, corticosterone in mice; Arnett et al., 2016; Gillespie et al.,
2009; Grad & Picard, 2007; Laryea, Arnett, & Muglia, 2012; Schmidt
et al., 2003). In addition, genetic variation in these genes has been
repeatedly linked to individual variability in susceptibility for depres-
sion (Binder et al., 2004; Bradley et al., 2008; de Kloet et al., 2016; Liu
et al., 2006; Schatzberg et al., 2014; Velders et al., 2011).
For SI, we examined the gene encoding brain-derived neurotrophic
factor (BDNF). Identification of variants in BDNF have replicated in multiple
GWAS of SI (Furberg et al., 2010; Liu et al, 2019). BDNF regulates synaptic
plasticity and survival of cholinergic and dopaminergic neurons (Zhang &
Poo, 2001), and is thought to play a role in modulation of dopamine
reward circuits that promote continued use of nicotine after initial expo-
sure (Furberg et al., 2010). For smoking intensity, we examined the
CHRNA5 gene, which codes for the alpha-5 subunit of the nicotinic recep-
tors. CHRNA5, along with nicotinic receptor genes CHRNA3 and CHRNA4,
has been identified as a risk factor for heaviness of smoking (as defined by
CPD), and the development of lung cancer in GWAS (Furberg et al., 2010;
Liu et al., 2010; Thorgeirsson et al., 2010). We focused specifically on
CHRNA5 because it contains SNP rs16969968 (i.e., “Mr. Big”), which is
widely believed to be the causal variant underlying the GWAS signal in
the CHRNA5/CHRNA3/CHRNB4 regions. In particular, it is known to cause
an amino acid change in the alpha-5 subunit of the nicotinic receptors, and
experiments have found this change alters the responsiveness of the nico-
tinic receptors to nicotine (Bierut et al., 2008).
2.6 | Statistical analyses
2.6.1 | PGS analysis
To facilitate genome-wide identification of pleiotropic effects, we
estimated associations between PGSs and smoking phenotypes using
a linear regression model
Yi = β0 + β1 PGSi +PC
0
iβ2 + ϵi, ð1Þ
where Y is the SI or CPD status of individual i, and PCi is a vector that
includes the first 10 EA genetic PCs. To test for mediated pleiotropy
we ran the following additional regressions
CESDi = δ0 + δ1 PGSi +PC
0
iδ2 + εi , ð2Þ




iθ4 + μi , ð3Þ
where CESDi is the CES-D score for individual i and X is a matrix of
covariates that we include in our fully specified model (sex, educa-
tional attainment, age, and birth cohort). For mediation to hold, there
must be (a) an association between the depressive symptoms PGS
and smoking phenotype (SI or CPD) in Equation (1); (b) an association
between the depressive symptoms PGS and the intermediate or medi-
ator phenotype (CES-D) in Equation (2); and (c) an association
between the smoking and CES-D phenotypes in Equation (3) (Baron &
Kenny, 1986). Additionally, if these conditions hold, then the associa-
tion between the depressive symptoms PGS and smoking phenotype
must be less in Equation (3) than Equation (1).
To test if pleiotropic effects vary by gender we interacted sex
(1 = female; 0 = male) with the depressive symptoms PGS in our fully
specified model




iγ5 + σi: ð4Þ
If γ3 is significant even after adjusting for CES-D, this is evidence of
sex-specific biological pleiotropy. In additional specifications, we also
tested for sex-specific mediated pleiotropy by including a three-way
interaction between the depressive symptoms PGS, sex, and CES-D.
For ease of interpretation, we used a linear probability model (LPM) to
estimate results for the dichotomous SI phenotype, since marginal
effects or corresponding odds ratios for interaction terms in logit models
are difficult to interpret (Karaca-Mandic, Norton, & Dowd, 2012). Finally,
we also ran the same models in the reciprocal direction using PGSs for SI
or CPD as independent variables, SI or CPD phenotypes as mediators,
and the CES-D phenotype as the outcome. CPD models were analyzed
in the sample of current/former smokers and included an additional con-
trol for current/former smoker status. Regression analyses were carried
out using Stata 15 (StataCorp, 2017).
2.6.2 | SKAT analysis
We performed gene-region analysis (SKAT) on selected gene regions
for HPA-axis function (NR3C1, NR3C2, FKBP5, CRHR1) and smoking
behavior (BDNF and CHRNA5; Lee, 2013; Lee, Miropolsky, & Wu,
2013; Lee, Teslovich, Boehnke, & Lin, 2013; Wu et al., 2011). SKAT
aggregates genetic information across the region using a kernel func-
tion and uses a computationally efficient variance component test to
test for association. SKAT assumes the following genetic main effect
model for the SI phenotype:
logitP yi=1ð Þ= α0 +X0iα1 +G0i α2, ð5Þ
where the phenotype is dichotomous (0 = never smoker, 1 = ever
smoker). Here, α0 is an intercept term, Xi is a matrix of nongenetic
covariates (first 10 EA genetic PCs, CES-D, age, educational
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attainment, and birth cohort), and Gi = (gi1, … , gip) is a matrix of geno-
types (0, 1, 2). The vector of regression coefficients for the covariates
is represented by α1, and α2 is a vector of regression coefficients for
the p observed genetic variants in the region. A primary assumption of
SKAT is that each α2j, j = 1, …, p, follows an arbitrary distribution with
mean zero and variance w2j τ. The weights, wj, are specified based on
minor allele frequency (MAF). We weighted variants using the default
β(1, 25) weighting scheme to up-weight minor alleles. Testing H0 : τ = 0
is equivalent to testing H0 : α2 = 0. SKAT extends to the linear model
for CPD and CES-D, where the outcome is E(yi).
2.6.3 | iSKAT analysis
The iSKAT analysis is a gene or region based G × E interaction test
(Lin, Lee, Christiani, & Lin, 2013). Suppose n subjects are genotyped in
a region with p SNPs. For iSKAT, the interaction model for the SI phe-
notype is:
logitP yi=1ð Þ= α0 +X0iα1 +G0i α2 + α3 Femalei +G×Female0iα4, ð6Þ
where all symbols are as described above with the addition of the
environmental factor (Femalei) and its effect estimate (α3), as well as a
vector of effect estimates for G × Femalei (α4), which is an n × p
matrix of G × E interactions in the region. This model assumes that
each of the α4j, j = 1, …, p, independently follows an arbitrary distribu-
tion with mean zero and common variance τ2. Testing H0: τ
2 = 0 is
equivalent to testing H0: α4 = 0, which tests whether at least one of
the interaction terms is nonzero. iSKAT is robust to the proportion of
causal variants in the region, the signs and magnitudes of the rare var-
iants, and also controls for main effects of the rare variants (Lin et al.,
2013). Both SKAT and iSKAT analyses were performed using R (Lee,
Miropolsky, & Wu, 2013).
3 | RESULTS
3.1 | Descriptive statistics
Our analytic sample consisted of 4,597 females and 3,489 males.
Descriptive statistics by sex are reported in Table 2. Males were 13%
more likely to smoke than females (p < .001), and smoked 6.62 more
CPD, consistent with population estimates for similar birth cohorts
(CDC, 2008). Women in the HRS sample had significantly higher aver-
age CES-D scores (1.38) than men (1.04; p < .001), consistent with U.S
population prevalence estimates for depression by gender (Kessler
et al., 1994). In keeping with national trends for white men and women
from these birth cohorts, 89% completed at least a GED/HS degree
(Escobedo & Peddicord, 1996).
Table 3a,b presents zero order correlations between all study
variables for the full sample and for males and females separately.
In the full sample, the depressive symptoms, SI, and CPD PGSs
were all significantly correlated with their intended phenotypes (all
p < .001). These correlations replicated in the sex-specific samples,
though some correlations (i.e., SI PGS and SI, SI PGS and current
smoker, depressive symptoms PGS and SI) were somewhat stronger
in females than males. In all three samples, the depressive symp-
toms PGS was not correlated with the CPD phenotype. Finally,
completion of a GED/high school degree, age, and birth cohort (not
shown) were correlated with smoking and CES-D, justifying their
inclusion as potential confounders in the analysis.
3.2 | PGS results
3.2.1 | Depressive symptoms PGS to smoking
phenotypes
Table 4 presents results from the multiple regression PGS analyses that
test for pleiotropic effects at the genome-wide level for the depressive
symptoms PGS and smoking phenotypes. Due to the null zero order corre-
lations between the depressive symptoms PGS and the CPD phenotype
reported in Table 3a,b,we focus on results for SI in themain text and report
results for CPD in the Appendix (Table A1). For all PGS analyses, we used a
Bonferroni adjusted alpha level of 0.006 (0.05/8 = 0.006). To see if
accounting for LD in PGS construction affected our estimates, analogous
results using a PGS for depressive symptoms constructed with LDpred are
presented in Table A2.
We found pleiotropic effects in both sexes, as evidenced by the
significant association between the depressive symptoms PGS
regression coefficient (β) and the SI phenotype in Model 1, Column
2 (p = .005). The coefficient was positive, suggesting that greater
genetic propensity for depressive symptoms was associated with
an increased risk of SI. However, following adjustment for the CES-
D phenotype, the depressive symptoms PGS coefficient was no
longer statistically significant after multiple comparison correction
(Model 2; p = .064). This, in combination with the highly significant
association between the depressive symptoms PGS and CES-D in
Model 1, Column 1 (p = 7.90E−21), is evidence of mediated
pleiotropy—i.e., the depressive symptoms PGS was associated with
both phenotypes when tested separately but appears to be more
directly related to the CES-D phenotype (Figure 3). We did not find
evidence of sex-specific biological pleiotropy from the regression
coefficient on the two-way interaction term in Model 5 (“DS PGS ×
Female”, p = .444), or sex-specific mediated pleiotropy from the
three-way interaction term coefficient in Model 6 (“DS PGS × CES-
D × Female”, p = .673). There was no evidence of biological, medi-
ated, or sex-specific mediated pleiotropy between the depressive
symptoms PGS and the CPD phenotype (Table A1). Accounting for
LD in PGS construction did not affect our results (Table A2).
3.2.2 | Smoking PGSs to depressive symptoms
phenotype
In Tables 5 and 6, we present results in the reciprocal direction that
tested for genome-wide pleiotropy between the SI and CPD PGSs and
the CES-D phenotype. Evidence of mediated pleiotropy was found for
both PGSs: the SI PGS was associated with CES-D (Table 5, Model
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1, Column 2; p = .002) and partially mediated by the SI phenotype
(Table 5, Model 2; p = .031; Figure 3); the CPD PGS was associated with
CES-D (Table 6, Model 1, Column 2; p = .034) and partially mediated by
the CPD phenotype (Table 6, Model 2; p = .046), though the results for
CPD were not as robust as those for SI and do not pass tests for multiple
comparisons. In both models, sex-specific mediated pleiotropy was not
observed.
Results from an exploratory cross-ancestry replication in the AA
sample are reported in Tables S3–S6 in Data S1 Supporting Informa-
tion. We caution that these results are not directly comparable with EA
results because the PGSs were constructed using results from an EA
GWAS. The depressive symptoms PGS was associated with CES-D in
the AA sample (Table S3, Model 1, Column 1; p = .005), but apart from
this, findings were null for the AA sample and the EA PGS results did
not replicate.
3.3 | SKAT and iSKAT results
Pleiotropic effects at the gene-region level for the SI, CPD, and CES-
D phenotypes are reported in Tables 7 and 8. p-Values for the joint
effect of all SNPs within each HPA-axis gene region (NR3C1, NR3C2,
FKBP5, and CRHR1) on the SI phenotype are reported in the top half
of the table, and p-values for the joint effect of SNPs within gene
regions for smoking on the CES-D phenotype (BDNF and CHRNA5)
are reported in the bottom half of the table. A significant p-value indi-
cates that the joint variance of the SNP effect sizes within a gene
region is statistically different from zero (i.e., one or more SNPs within
the gene region have a statistically significant association with the
phenotype). Models 1–4 test the association between each gene
region with and without adjustments for covariates (SKAT), and
Model 5 adds a sex-specific gene region interaction to the fully
adjusted model (iSKAT).
3.3.1 | HPA-axis gene regions to smoking
phenotypes
SKAT and iSKAT tests for the four HPA-axis gene regions were con-
ducted using Bonferroni-adjusted alpha levels of 0.003 (0.05/20 = 0.003).
We observed some preliminary evidence of biological pleiotropy in males
and females in FKBP5, and evidence of sex-specific biological pleiotropy
in females in NR3C2 (Table 7). Pleiotropy was not observed in NR3C1
(Model 4, p = .955; Model 5, p = .321) or CRHR1 (Model 4, p = .809;
Model 5, p = .161). Within FKBP5, the joint variance of the SNP-set
(nSNP = 286) was significantly different from zero for the SI phenotype
(Model 1, p = .017), and the p-value remained significant at p < .05 after
controlling for CES-D (Model 2, p = .019), and after adjusting for covariates
(Model 4, p = .028). Thus, in contrast to the PGS results, we did not find
any evidence of mediated pleiotropy by the CES-D phenotype—i.e., the
TABLE 2 Descriptive statistics of
study variables for the full sample, males,




N 8,086 3,489 4,597
Smoking initiation 4,657 (58) 2,284 (65) 2,373 (52) 4.91E−36
Cigarettes per day (CPD)a 24.21 (16.77) 27.58 (18.05) 20.96 (14.73) 5.81E−42
Current smoker 1,981 (24) 870 (25) 1,111 (24) 4.27E−01
Mean CES-D 1.23 (1.41) 1.04 (1.29) 1.38 (1.47) 3.93E−28
Depressive symptoms
PGS
0 (1.00) 0.01 (0.99) −0.01 (1.01) 4.03E−01
Smoking initiation PGS 0 (1.00) −0.01 (1.00) 0.01 (1.00) 3.06E−01
CPD PGSa 0 (1.00) −0.02 (0.99) 0.02 (1.01) 1.02E−01
Ageb 61.62 (6.20) 62.15 (5.92) 61.21 (6.37) 1.31E−11
Education
No degree 858 (11) 355 (10) 503 (11) 2.67E−01
GED or HS degree 4,547 (56) 1,818 (52) 2,729 (59) 6.87E−11
College degree 2,681 (33) 1,316 (38) 1,365 (30) 2.86E−14
Birth cohort
1930–1935 1,772 (22) 790 (23) 982 (21) 1.68E−01
1936–1941 2,173 (27) 989 (28) 1,184 (26) 9.25E−03
1942–1947 1,529 (19) 602 (17) 927 (20) 9.28E−04
1948–1953 1,631 (20) 732 (21) 899 (20) 1.14E−01
1954–1959 981 (12) 376 (11) 605 (13) 1.14E−03
Note: Data are in n (%) or mean (SD).
aCPD statistics are calculated for the sample of respondents who are current or former smokers.
bSample mean of respondents' mean age across their observations (all: N = 4,641; males: N = 2,275;
females: N = 2,366).
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association between FKBP5 and the SI phenotype was not significantly
attenuated after controlling for CES-D. These results suggest biological
pleiotropy, or one gene predicting several phenotypes. We did not
observe evidence of sex-specific pleiotropy in FKBP5 (Model 5, p = .545), a
finding that is consistentwith the genome-wide PGS analyses. Conversely,
in NR3C2, the interaction term in the iSKAT model for the SNP-set
(nSNP = 1,138) was significantly different from zero (Model 5; p = .030),
suggesting the presence of sex-specific biological pleiotropy. In keeping
with the PGS results, evidence of pleiotropy between HPA-axis related
genes and the CPDphenotypewas not observed (Table 8).
Overall, results are suggestive as they are not significant after
adjusting for multiple testing. Moreover, results from iSKAT do not
allow us to test the direction of the sex-specific interaction effect or
determine which variants within NR3C2 may be driving the interac-
tion. As a result, future studies in larger samples are needed to
determine whether SNPs in this region may have protective or delete-
rious effects on SI in males versus females.
3.3.2 | Smoking gene regions to depressive
symptoms phenotype
SKAT and iSKAT tests for the two smoking gene regions were conducted
using Bonferroni-adjusted alpha levels of 0.006 (0.05/8 = 0.006). We
found no evidence of biological or mediated pleiotropy between BDNF
or CHRNA5 and the CES-D phenotype in models that controlled for the
SI phenotype (Table 7). In models that adjusted for the CPD phenotype,
the iSKAT coefficient for the CHRNA5 SNP-set (nSNP = 107) was signifi-
cantly different from zero (Table 8, Model 5; p = .025), suggesting sex-
specific biological pleiotropy between CHRNA5 and the CES-D
TABLE 3 (a) Correlations between study variables; (b) correlations between study variables by sex
(a) European ancestry sample, N = 8,086





Current smoker 0.489*** −0.078*** 1
Mean CES-D 0.103*** 0.034** 0.193*** 1
DS PGS 0.023** −0.010 0.049*** 0.101*** 1
SI PGS 0.122*** −0.001 0.077*** 0.053*** 0.067*** 1
CPD PGS 0.026** 0.057*** 0.045*** 0.033*** −0.013 0.031*** 1
Mean age 0.027** 0.116*** −0.081*** −0.078*** 0.000 −0.008 0.023** 1
GED/HS degree −0.086*** −0.076*** −0.119*** −0.187*** −0.042*** −0.032*** −0.048*** −0.132*** 1






CES-D DS PGS SI PGS CPD PGS Mean age
GED/HS
degree
Males SI 1 NA 0.547*** 0.141*** 0.030** 0.148*** 0.020 −0.016 −0.095***
CPDa NA 1 −0.015 0.078*** −0.002 0.017 0.062*** 0.035* −0.081***
Current
smoker
0.419*** −0.105*** 1 0.200*** 0.046*** 0.108*** 0.059*** −0.080*** −0.131***
Mean
CES-D
0.093*** 0.057*** 0.189*** 1 0.104*** 0.054*** 0.035** −0.056*** −0.215***
DS PGS 0.011 −0.017 0.052*** 0.101*** 1 0.076*** −0.003 0.005 −0.050***
SI PGS 0.092*** 0.003 0.036** 0.049*** 0.055*** 1 0.035** −0.002 −0.041***
CPD PGS 0.044*** 0.065*** 0.028* 0.021 −0.026 0.025 1 0.026* −0.071***
Mean age 0.064*** 0.158*** −0.085*** −0.092*** −0.009 −0.013 0.025 1 −0.129***
GED/HS
degree
−0.079*** −0.087*** −0.104*** −0.143*** −0.032* −0.019 −0.016 −0.139*** 1
Abbreviations: CES-D, Center for Epidemiological Studies-Depression 8 item scale; DS, depressive symptoms; GED, general education degree; HS, high
school degree; PGS, polygenic score; SI, smoking initiation.
aCPD column is calculated for the population of respondents who report ever smoking (all: N = 4,641; males: N = 2,275; females: N = 2,366).
*p < .10; **p < .05; ***p < .01.
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phenotype. However, results did not pass tests for multiple comparisons
and are therefore suggestive.
SKAT and iSKAT results for individuals of AA are reported in
Tables S7 and S8. Unlike the PGS analysis, results from gene region
analysis are more directly comparable across ancestral populations
because the level of inference is the gene region, which is defined
equivalently across all ancestral populations and (presumably) has the
same biological function. However, reduced sample size coupled with
shorter LD blocks, greater haplotype diversity, and genotyping chips
designed to tag European variants means we were likely underpow-
ered to detect effects in the HRS AA sample. In general, SKAT and
iSKAT findings were null in the AA sample, and EA findings for FKBP5
and NR3C2 did not replicate.
4 | DISCUSSION
We used two statistical approaches to test for biological and mediated
pleiotropy between genetic risk factors for depressive symptoms and
smoking behavior. Using a polygenic approach, we found evidence of
mediated pleiotropy in both males and females. Results were significant
in both directions—i.e., the PGS for depressive symptoms was associ-
ated with increased risk of SI, and the PGS for SI was associated with a
higher CES-D score. Results from SKAT and iSKAT showed preliminary
evidence of biological pleiotropy for FKBP5 in the combined sample,
and sex-specific biological pleiotropy in NR3C2. In contrast to the PGS
results, we found no evidence of mediated pleiotropy, and no evidence
of pleiotropy in the reciprocal direction, or between smoking genes
(BDNF and CHRNA5) and CES-D in the full sample. Conversely, in the
sample of current or former smokers, CHRNA5 was associated with the
CPD phenotype, and there was preliminary evidence for sex-specific
pleiotropy between CHRNA5 and CES-D.
Together, these results suggest that bidirectional associations
between depressive symptoms and SI may be partially accounted for
by shared genetic factors, and that on average these pleiotropic
effects do not vary by sex on the genome-wide level. At finer levels of
observation, results for females suggest that genes related specifically
to HPA-axis functioning may contribute to SI, and following initiation,
genetic factors related to nicotine dependence may further contribute
to an increase in depressive symptoms. However, after Bonferroni
correction, the SKAT and iSKAT results we report for FKBP5 and
NR3C2 were not significant at p < .05. Thus, we caution these results
are suggestive, and further analyses in larger samples are needed to
confirm the associations we report. In addition, because the HRS is a
representative sample of older adults, we cannot discern when in the
life course the onset of depressive symptoms occurred and whether it
proceeded tobacco use (Fluharty et al., 2016). Therefore, longitudinal
analyses in younger cohorts, and/or different methodologies that can
draw stronger conclusions regarding causality, are needed to confirm
the direction of the association between genetic risk for depression
and smoking behavior.
4.1 | Sex-specific pleiotropy in NR3C2
Preliminary evidence of sex-specific pleiotropic effects within NR3C2
in the HRS is consistent with research that reports sex-differences in
basal levels of HPA-axis functioning among older adults with depres-
sion. NR3C2 encodes the mineralocorticoid receptor (MR), of which
cortisol has a higher affinity for and thus, in part, determines basal
HPA-axis functioning (De Kloet, Vreugdenhil, Oitzl, & Joels, 1998;
Gunnar & Quevedo, 2007). In a meta-analysis of 20 studies of adults
older than 60 years, significantly larger effect sizes for the association
between morning basal cortisol and depression were reported in
women compared to men (Murri et al., 2014). Moreover, though the
current sample was composed of older postmenopausal women, a
recent study in premenopausal women found that genetic variation
within the MR gene moderated the impact of progesterone and estra-
diol on markers of negative affect (i.e., anxiety, emotion recognition;
Hamstra et al., 2017). Thus, more research is needed to investigate
the interplay of genetic risk for HPA-axis function dysregulation, ovar-
ian hormones, and both depression and smoking behaviors among
women across the lifespan.
In addition to biological reasons why women may be at greater risk
for depression-related phenotypes and downstream compensatory
behaviors (e.g., smoking), some research suggests that women are more
likely to rate negative life events as stressful (Kessler & McLeod, 1984)
and to report more negative affect than men (Hankin & Abramson,
2001; Watson, Clark, & Tellegen, 1988). Given that other research has
challenged the assumption of reporting differences between men and
F IGURE 3 Mediated pleiotropy results from polygenic score
(PGS) analyses. Results are from Tables 4 and 5, Models 1 and 2. All
models adjust for 10 European ancestry genetic PCs. CES-D, Center
for Epidemiological Studies-Depression 8 item scale; PGS, polygenic
score; SI, smoking initiation
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women (Kendler, Thornton, & Prescott, 2001; Martin, Neighbors, &
Griffith, 2013), more research is needed to understand the biological
and social factors that contribute to gender-based discrepancies in
psychopathology.
In contrast to previous research (e.g., Rogausch et al., 2007;
Tang et al., 2015), genetic variation within the NR3C1 and CRHR1
was not associated with smoking behavior independent of depres-
sive symptoms in the current sample. As neither of these studies
accounted for depressive symptoms in their analysis, it may be that
genetic variation within these two genes are associated with
smoking behavior insofar as nicotine use is comorbid with depres-
sion (Kessler et al., 1994; Torres & O'Dell, 2016). These results
highlight the relevance of considering pleiotropic effects within the
psychiatric literature, as comorbidity is extremely common (Kessler
et al., 1994).
Notably, we did not find evidence of pleiotropy between dep-
ression/HPA-axis related PGS/genes and CPD, suggesting genetic risk
factors for depression are more related to smoking onset and persistence
as opposed to smoking intensity. SI is thought to be a downstream con-
sequence of depression and negative affect (Kassel et al., 2003;
Torres & O'Dell, 2016), which may explain why genetic risk for depres-
sion and HPA-axis dysregulation was more strongly related to SI versus
CPD. Though further investigation is needed, evidence from behavioral
and molecular genetic studies suggest that genetic risk factors for SI
and CPD may be partially independent (Heath & Martin, 1993; Wang &
Li, 2010).
4.2 | Strengths and limitations
To our knowledge, this is the first study to use both PGSs and gene
region aggregation methods to test for pleiotropic effects. PGSs allow
us to estimate whether pleiotropy persists on a genome-wide level,
increasing our power to detect effects. However, this approach does
not elucidate the mechanisms of shared genetic liability for depression
and smoking. In addition, GWAS weights used to construct the PGS
for depressive symptoms did not condition on smoking behavior, and
may therefore capture genetic risk for depression as well as genetic
risk for endophenotypes like smoking that are associated with depres-
sive symptoms. This may in part explain why on a genome-wide level
we found strong evidence of mediated pleiotropy as opposed to bio-
logical pleiotropy. In addition, collapsing across all variants—some of
which may have weaker pleiotropic effects—introduces substantial
noise into the aggregated index, potentially attenuating evidence for
association. Using a PGS may also make it difficult to observe sex dif-
ferences in pleiotropy, since a genome-wide average might dilute sig-
nals at the gene level that are related to specific pathological
functions. Conversely, with the SKAT and iSKAT analyses, we were
able to pinpoint specific gene regions and associated biological
TABLE 7 Gene region marginal and joint effects p-values for smoking initiation and CES-D, sequence kernel association testing, European
ancestry (N = 8,086)
CES-D
Smoking initiation (SI)
Gene region p-value, SKAT Gene region p-value, SKAT G × E p-value, iSKAT
(optimal test rho)
Region location Model 1 Model 1 Model 2 Model 3 Model 4 Model 5
NR3C1 (nSNP = 211) 5q31.3 0.327 0.968 0.966 0.966 0.955 0.321 (1)
NR3C2 (nSNP = 1,147) 4q31.23 0.383 0.258 0.180 0.163 0.103 0.030 (0)
FKBP5 (nSNP = 286) 6p21.31 0.007 0.017 0.019 0.019 0.028 0.545 (0)
CRHR1 (nSNP = 1,185) 17q21.31 0.336 0.927 0.894 0.892 0.809 0.161 (0.2)
SI
Depressive symptoms (CES-D)
Gene region p-value, SKAT Gene region p-value, SKAT G × E p-value, iSKAT
(optimal test rho)
Region location Model 1 Model 1 Model 2 Model 3 Model 4 Model 5
CHRNA5 (nSNP = 107) 15q25.1 0.346 0.343 0.348 0.159 0.145 0.073 (0)
BDNF (nSNP = 152) 11p14.1 0.598 0.281 0.244 0.180 0.248 0.760 (0)
Note: We weighted variants using the default β(1, 25) weighting scheme to up-weight minor alleles. Optimal test rho: the value of rho to
maximize statistical power resulting in the best linear combination of SKAT and burden tests. Rho = 1 is equivalent to a burden test while
rho = 0 is equivalent to a SKAT test. Bonferroni-adjusted alpha level for SI results: *p < .003. Bonferroni-adjusted alpha level for CES-D
results: *p < .006.
Abbreviations: CES-D, Center for Epidemiological Studies-Depression 8 item scale; G × E, gene by environment; SKAT, sequence kernel association
testing; iSKAT, interaction SKAT.
M1: CES-D/SI = GENE + PCS.
M2: SI/CES-D = GENE + CES-D/SMOKE + PCS.
M3: SI/CES-D = GENE + CES-D/SMOKE + PCS + AGE + GED/HS + COHORT.
M4: SI/CES-D = GENE + FEMALE + CES-D/SMOKE + PCS + AGE + GED/HS + COHORT.
M5: SI/CES-D = GENE + FEMALE + FEMALE × GENE + CES-D/SMOKE + PCS + AGE + GED/HS + COHORT.
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processes that may contribute to sex differences in SI and CPD. This
approach requires a priori knowledge of potential candidate gene
regions and decisions on whether or not to weight certain (e.g., rare)
variants in the region. Both approaches were not able to detect epi-
static effects across genes, which may be particularly relevant in the
case of NR3C1 and NR3C2, since these receptors necessarily need
to act together to regulate different stages of the stress response
(Rovaris et al., 2016).
The use of a large, population representative cohort of individ-
uals from the same ancestral group is an advantage of this study in
that it both increases our power to detect pleiotropic effects while
also minimizing the presence of ascertainment bias. Ascertainment
bias can induce spurious cross-phenotype correlations in clinical
studies if, for example, patients suffering from depression and
smoking (or a third related phenotype) are more likely to seek treat-
ment than those suffering from only one condition (Smoller,
Lunetta, & Robins, 2000). However, population-based studies are
susceptible to biases in measurement error (Liao et al., 2014). CES-
D in particular may not adequately capture more proximal biologi-
cal processes involved in HPA-axis regulation, reducing our power
to detect effects. Studies with in-depth clinical and multi-informant
measures of psychopathology, HPA-axis functioning, and smoking
are needed to further refine the associations we observed. More-
over, because the HRS is a sample of older individuals, results may
be subject to mortality selection, which would bias the effects we
observe downwards if individuals who survived to older ages were
less likely to smoke and/or report symptoms of depression. To
reduce the potential of mortality selection, we limited our analyses
to individuals born after 1930.
Finally, a significant limitation of this study is that were limited to
conducting analyses in individuals of European decent. Although we
report findings for individuals of AA, we did not include these results in
the main text because comparable GWAS in other ancestral populations
are currently unavailable. Estimates from an EA GWAS are not necessar-
ily accurate or valid in other ancestral populations, and PGSs constructed
from EA GWAS summary statistics will not have the same predictive
power for individuals from other ancestral backgrounds (Carlson et al.,
2013; Martin et al., 2017). Thus, we caution that our EA PGS results can-
not be generalized to other ancestral populations. Although SKAT and
iSKAT results are more directly comparable across ancestral groups, the
relatively small sample size of AA individuals in the HRS in addition to
shorter LD blocks, greater haplotype diversity, and the use of genotyping
chips that were designed to tag European variants means that we were
likely underpowered to draw meaningful conclusions at the gene level.
4.3 | Conclusions
From a public health perspective, understanding the degree to which
genetic risk for depression contributes to sex differences in SI, main-
tenance, and relapse, has important implications for smoking cessation
TABLE 8 Gene region marginal and joint effects p-values for cigarettes per day and CES-D, sequence kernel association testing, European
ancestry (N = 4,641)
CES-D
Cigarettes smoked per day (CPD)
Gene region p-value, SKAT Gene region p-value, SKAT G × E p-value, iSKAT
(optimal test rho)
Region location Model 1 Model 1 Model 2 Model 3 Model 4 Model 5
NR3C1 (nSNP = 211) 5q31.3 0.838 0.106 0.068 0.085 0.154 0.500 (0)
NR3C2 (nSNP = 1,147) 4q31.23 0.209 0.466 0.453 0.452 0.709 0.305 (0)
FKBP5 (nSNP = 286) 6p21.31 0.029 0. 784 0.783 0.824 0.822 0.673 (0)
CRHR1 (nSNP = 1,185) 17q21.31 0.579 0. 607 0.725 0.689 0.689 0.765 (0)
CPD
Depressive symptoms (CES-D)
Gene region p-value, SKAT Gene region p-value, SKAT G × E p-value, iSKAT
(optimal test rho)
Region location Model 1 Model 1 Model 2 Model 3 Model 4 Model 5
CHRNA5 (nSNP = 107) 15q25.1 0.011 0.663 0.641 0.593 0.580 0.025 (0)
BDNF (nSNP = 152) 11p14.1 0.301 0.770 0.789 0.815 0.692 0.540 (0)
Note: We weighted variants using the default β(1, 25) weighting scheme to up-weight minor alleles. Optimal test rho: the value of rho to maximize
statistical power resulting in the best linear combination of SKAT and burden tests. Rho = 1 is equivalent to a burden test while rho = 0 is equivalent to a
SKAT test. Sample includes current or former smokers only. Bonferroni-adjusted alpha level for CPD results: *p < .003. Bonferroni-adjusted alpha level for
CES-D results: *p < .006.
Abbreviations: CES-D, Center for Epidemiological Studies-Depression 8 item scale; G × E, gene-by-environment; SKAT, sequence kernel association
testing; iSKAT, interaction SKAT.
M1: CES-D/CPD = GENE + PCS.
M2: CPD/CES-D = GENE + CES-D/CPD + PCS.
M3: CPD/CES-D = GENE + CES-D/CPD + PCS + AGE + CURRENT SMOKER + GED/HS + COHORT.
M4: CPD/CES-D = GENE + FEMALE + CES-D/CPD + PCS + AGE + CURRENT SMOKER + GED/HS + COHORT.
M5: CPD/CES-D = GENE + FEMALE + FEMALE × GENE + CES-D/CPD + PCS + AGE + CURRENT SMOKER + GED/HS + COHORT.
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therapy. In particular, while nicotine replacement therapy alone is the
most common treatment for smoking cessation (Burton, Gitchell, &
Shiffman, 2000), if genetic risk for depression plays a larger role in
female nicotine dependence, then tailored interventions for smoking
cessation that include nonpharmacological treatments may be neces-
sary (Reynoso et al., 2005). Our findings suggest that common genetic
factors contribute to comorbidity between depressive symptoms and
smoking behavior with some suggestive evidence of female-specific
pleiotropy in genes that have been linked to HPA-axis function and
smoking intensity. As a result, future GWAS studies of behavioral and
mental health phenotypes should consider reporting summary statistics
by sex, particularly if prevalence rates differ dramatically between
males and females. Overall, further research is needed to assess the
replicability of our findings and, more broadly, the degree to which sex-
specific dysregulation of the HPA-axis and depression-related genes
play a fundamental role in nicotine dependence.
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